American Journal of Cardiology
Volume 106, Issue 3 , Pages 337-341 , 1 August 2010

Comparison of Sirolimus-Eluting Stents With Paclitaxel-Eluting Stents in Saphenous Vein Graft Intervention (from a Multicenter Southern California Registry)

  • Michael S. Lee, MD

      Affiliations

    • Division of Cardiology, University of California, Los Angeles Medical Center, Los Angeles, California
    • Corresponding Author InformationCorresponding author: Tel: 310-267-8024; fax: 310-267-3525
    • ,
  • Patrick P. Hu, MD

      Affiliations

    • Division of Cardiology, University of California, San Diego Medical Center, San Diego, California
    • ,
  • Joseph Aragon, MD

      Affiliations

    • Santa Barbara Cottage Hospital, Santa Barbara, California
    • ,
  • Atman P. Shah, MD

      Affiliations

    • Division of Cardiology, University of Chicago, Chicago, Illinois
    • ,
  • Jared Oyama, MD

      Affiliations

    • Division of Cardiology, University of California, Los Angeles Medical Center, Los Angeles, California
    • ,
  • Jashdeep Dhoot, MD

      Affiliations

    • Division of Cardiology, University of California, Los Angeles Medical Center, Los Angeles, California
    • ,
  • Zahid Iqbal, BA

      Affiliations

    • Division of Cardiology, University of California, Los Angeles Medical Center, Los Angeles, California
    • ,
  • Nathaniel Jones, BS

      Affiliations

    • Santa Barbara Cottage Hospital, Santa Barbara, California
    • ,
  • William Penny, MD

      Affiliations

    • Division of Cardiology, VA San Diego Healthcare System, San Diego, California
    • ,
  • Jonathan Tobis, MD

      Affiliations

    • Division of Cardiology, University of California, Los Angeles Medical Center, Los Angeles, California
    • ,
  • Ehtisham Mahmud, MD

      Affiliations

    • Division of Cardiology, University of California, San Diego Medical Center, San Diego, California
    • ,
  • William French, MD

      Affiliations

    • Division of Cardiology, Harbor-UCLA Medical Center, Torrance, California

Received 26 January 2010 ,Revised 11 March 2010 ,Accepted 11 March 2010.

References 

  1. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28:616–626
  2. Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easley K, Taylor PC. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg. 1985;89:248–258
  3. Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery. J Am Coll Cardiol. 2004;44:2149–2156
  4. Yap C, Sposato L, Akowuah E, Theodore S, Dinh DT, Shardey GC, et al. Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality. Ann Thorac Surg. 2009;87:1386–1391
  5. Stephan WJ, O'Keefe JH, Piehler JM, McCallister BD, Dahiya RS, Shimshak TM, et al. Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery. J Am Coll Cardiol. 1996;28:1140–1146
  6. Savage MP, Douglas JS, Fischman DL, Pepine CJ, King SB, Werner JA, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med. 1997;337:740–747
  7. Brener SJ, Ellis SG, Apperson-Hansen C, Leon MB, Topol EJ. Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years. Am J Cardiol. 1997;79:13–18
  8. Kimura T, Nosaka H, Yokoi H, Iwabuchi M, Nobuyoshi M. Serial angiographic follow-up after Palmaz-Schatz stent implantation: comparison with conventional balloon angioplasty. J Am Coll Cardiol. 1993;21:1557–1563
  9. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356:1020–1029
  10. Kastrati A, Dibra A, Eberle S, Stat D, Mehilli J, Suarez de Lezo J, et al. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA. 2005;294:819–825
  11. Sidhu S, Shafiq N, Malhotra S, Pandhi P, Grove A. A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease. Br J Clin Pharmacol. 2006;61:720–726
  12. Schomig A, Dibra A, Windecker S, Mehilli J, Suarez de Lezo J, Kaiser C, et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol. 2007;50:1373–1380
  13. Gurm H, Boyden T, Welch KB. Comparative safety and efficacy of a sirolimus-eluting versus paclitaxel-eluting stent: a meta-analysis. Am Heart J. 2008;155:630–639
  14. Brilakis ES, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Haagen D, et al. A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions. J Am Coll Cardiol. 2009;53:919–928
  15. Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Bruining N, et al. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts. J Am Coll Cardiol. 2006;48:2423–2431
  16. Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Van den Branden F, et al. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts. J Am Coll Cardiol. 2007;50:261–267
  17. Chu WW, Kuchulakanti PK, Wang B, Clavijo LC, Suddath WO, Pichard AD, et al. Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft intervention. J Interv Cardiol. 2006;19:121–125
  18. Gormez S, Erdim R, Erdogmus O, Civan M, Catakoglu AB, Gulbaran M, et al. Treatment of saphenous vein graft lesions with paclitaxel- and sirolimus-eluting stents: comparison of short- and long-term clinical outcomes. Anadolu Kardiyol Derg. 2008;8:431–436
  19. Bavry AA, Kumbhani DJ, Helton TJ, Bhatt DL. Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data). Am J Cardiol. 2005;95:1469–1472
  20. Bavry AA, Kumbhani DJ, Helton TJ, Bhatt DL. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: A meta-analysis. J Am Coll Cardiol. 2005;45:941–946
  21. Moreno R, Fernández C, Hernandez R, Alfonso F, Angiolillo DJ, Sabate M, et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol. 2005;45:954–959
  22. Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med. 2006;119:1056–1061
  23. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667–678
  24. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998–1008

PII: S0002-9149(10)00779-4

doi: 10.1016/j.amjcard.2010.03.030

American Journal of Cardiology
Volume 106, Issue 3 , Pages 337-341 , 1 August 2010

Article Tools

* Image Usage & Resolution